Scientists at the Broad Institute and Mass General Brigham have built a generative AI model that creates short DNA segments ...

OXFORD, England--(BUSINESS WIRE)--British techbio innovator Etcembly is coming out of stealth mode, kickstarting the next generation of immunotherapies with a pipeline of best-in-class T cell receptor ...

Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Precision oncology in non–small ...

—Researchers in Italy recently evaluated the ability of an artificial intelligence (AI) chatbot to recommend diagnostic and therapeutic approaches to care for patients with renal cell carcinoma (RCC).

An AI tool that can analyse abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukaemia are ...